Headline miss
Reaction to come.
Reaction to come.
Most Popular
Sponsored
JLL beats revenue/EPS estimates, but macro risks loom. AI boosts productivity, yet Asia Pacific contracts weigh.
MA beats Q1 earnings, revenue up 15.8%. Geopolitics pressure cross-border, but value-added services grow 18%.
ILMN beats revenue/EPS estimates, lifts guidance. Clinical demand & NovaSeq X drive growth. Buy?
Ube prices surge 38% amid supply chain strain & 20% export growth. Farmers face rising costs, impacting returns.
Hormuz deadlock persists, oil prices soar on supply loss. Recession fears rise as buffers exhaust.
CARR beats revenue/EPS estimates! Data center surge fuels growth, but tariffs bite. Buy now?
AI powers nuclear SMRs! BWXT & RYCEY offer stable returns with 10%+ margins & strong EPS growth.
Sponsored
Must Read